EBSEMERGENT BIOSOLUTIONS INC

CUSIP: 29089Q105

No superinvestors currently hold this stock.

📊 Fundamentals

Market Cap$417.3M

P/E Ratio8.7x

Below market avg

Forward P/E2.7x

P/FCF2.0x

EPS (TTM)$0.93

Revenue (TTM)$742.9M

Profit Margin7.08%

Beta2.36

52-Week Range

$4.45

$14.06

Current: $8.06

Data from Yahoo Finance · refreshed every 4 hours

💡 Trades at 8.7x trailing earnings → 2.7x forward · 7.1% profit margin

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

📊 Adjust the assumptions below to calculate an estimated fair value

Projection Period

Revenue Growth Rate

20%analyst est. 19.7%

0%100%

Growth Decay Rate

15%

0% (no decay)50% (fast decay)

Terminal Growth Rate

3.0%

0%5%

FCF Margin

27.6%current: 27.6%

1%50%

Discount Rate (WACC)

8.0%typical: 8% large caps · 10% growth

5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data

EBS: Held by 0 superinvestors · 1 congress member trade

$1,001 - $15,0002024-12-11